Literature DB >> 3896473

Obligate genetic expression in tumor cells of a fetal membrane property mediating "folate" transport: biological significance and implications for improved therapy of human cancer.

F M Sirotnak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3896473

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  26 in total

Review 1.  Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials.

Authors:  Jaesung Kim; Pyung-Hwan Kim; Sung Wan Kim; Chae-Ok Yun
Journal:  Biomaterials       Date:  2011-12-03       Impact factor: 12.479

2.  The human reduced folate carrier gene is ubiquitously and differentially expressed in normal human tissues: identification of seven non-coding exons and characterization of a novel promoter.

Authors:  Johnathan R Whetstine; Robin M Flatley; Larry H Matherly
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

Review 3.  Resistance to cytostatic drugs at the cellular level.

Authors:  C P Vendrik; J J Bergers; W H De Jong; P A Steerenberg
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 4.  Molecular mechanisms of drug resistance.

Authors:  J D Hayes; C R Wolf
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

5.  Structure and function of the reduced folate carrier a paradigm of a major facilitator superfamily mammalian nutrient transporter.

Authors:  Larry H Matherly; Zhanjun Hou
Journal:  Vitam Horm       Date:  2008       Impact factor: 3.421

6.  Methotrexate Resistance in Datura innoxia (Uptake and Metabolism of Methotrexate in Wild-Type and Resistant Cell Lines).

Authors:  K. Wu; I. J. Atkinson; E. A. Cossins; J. King
Journal:  Plant Physiol       Date:  1993-02       Impact factor: 8.340

7.  The folate receptor works in tandem with a probenecid-sensitive carrier in MA104 cells in vitro.

Authors:  B A Kamen; A K Smith; R G Anderson
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

8.  Transcript heterogeneity of the human reduced folate carrier results from the use of multiple promoters and variable splicing of alternative upstream exons.

Authors:  L Zhang; S C Wong; L H Matherly
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

9.  Stable transfectants of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to antifolates.

Authors:  K N Chung; Y Saikawa; T H Paik; K H Dixon; T Mulligan; K H Cowan; P C Elwood
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

10.  Transfection of a glycosylated phosphatidylinositol-anchored folate-binding protein complementary DNA provides cells with the ability to survive in low folate medium.

Authors:  C A Luhrs; C A Raskin; R Durbin; B Wu; E Sadasivan; W McAllister; S P Rothenberg
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.